MCT2D Welcomes New Program Leadership

Caroline Richardson has stepped down from her role as the program director of the Michigan Collaborative for Type 2 Diabetes effective July 14th to take a role as the chair of family medicine at Brown University. The MCT2D team is incredibly grateful to Dr. Richardson for her vision in establishing the program and leadership in its initial year. We are confident that the strong foundation on which the program was built, will foster continued improvement in type two diabetes care for years to come. More information will be forthcoming, but there will be no changes to the operations of MCT2D. Thank you Dr. Richardson for all that you have done to support our successful launch.

A Note from the Outgoing Director

Recent improvements in medication, technology and dietary counseling for Type 2 Diabetes have the potential to dramatically improve patients’ lives. However, keeping up with all the changes and recommendations can be challenging, and no single provider can go at it alone. In 2021, we established MCT2D as a statewide collaborative designed to support Michigan physicians and care teams as we shift the paradigm of T2D care together, delivering the kind of state-of-the-art care our patients deserve.
During our first year, with input from participating physician organizations, practices, and patients from across the state, we have developed tools and educational programs to reduce barriers to delivery of high-quality Type 2 Diabetes care. And we are just getting started!
It has been a privilege to lead the collaborative during the first year. I am grateful for the support and collaboration from so many individuals and organizations from across the state. I will be handing over the leadership of the collaborative to a new team of co-directors as of July 14, as I have accepted a new position outside of the state of Michigan, as Chair of Family Medicine at The Warren Alpert Medical School of Brown University. Our fantastic team of quality improvement specialists, designers, data managers, data analysts, and clinical experts will continue the important work of the collaborative.
Caroline Richardson, MD

NEW PROGRAM LEADERSHIP

We are incredibly excited to announce Dr. Oshman as the new MCT2D Program Director!
Dr. Lauren Oshman, MD, MPH, FAAFP, Dipl. ABOM, a family physician and associate professor of family medicine at the University of Michigan Medical School, Diplomate of the American Board of Obesity Medicine (ABOM), and former MCT2D program co-director has assumed the role of MCT2D lead program director. Dr. Oshman brings years of experience in quality improvement and physician leadership to this role. As program co-director, she guided the collaborative through the design and dissemination of practice change readiness assessments and focused on the development of numerous clinician and patient facing tools, advocacy, and clinician education on MCT2D’s three pillars. 
We are incredibly excited to announce Dr. Oshman as the new MCT2D Program Director!
headshot of Heidi Diez
Dr. Heidi Diez, PharmD, BCACP, a clinical pharmacist in Family Medicine at Michigan Medicine, joined the MCT2D team in September 2021, as the lead pharmacist. In her first year with MCT2D, Heidi co-led MCT2D’s Medication Training series and developed several MCT2D tools related to medication prescribing, side effect management and cost savings for use by both prescribers and patients. Heidi has established herself as a patient advocate to stakeholders in the state regarding the expansion of coverage of continuous glucose monitors for patients with Type 2 Diabetes. She has also recorded a series of videos for the MCT2D website to help our participants educate their patients when starting various injectable Glucagon-like peptide-1 (GLPs) receptor agonists. Finally, she presented  MCT2D’s first year findings by giving a podium and poster presentation at the American Diabetes Association’s 82nd Scientific Session meeting in New Orleans in June 2022. Dr. Lauren Oshman, incoming MCT2D Program Director had this to say about Heidi’s appointment as co-director: “Heidi is passionate about making sure that people with diabetes get exceptional care. Whether that means better education, fighting for insurance coverage of their medications, or helping them troubleshoot their treatment, her focus on high-quality care makes her an ideal match for MCT2D.”

Subscribe to the MCT2D Newsletter

* indicates required
Blue Cross Blue Shield Blue Care Network of Michigan

Support for the Michigan Collaborative on Type 2 Diabetes is provided by Blue Cross Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs. To learn more about Value Partnerships, visit www.valuepartnerships.com. Although Blue Cross Blue Shield of Michigan and the Michigan Collaborative on Type 2 Diabetes work in partnership, the opinions, beliefs, and viewpoints expressed by MCT2D do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.